Use Cases

Aotearoa Clinical Trials

Aotearoa Clinical Trials: Improving Clinical Trial Management with AI

Project Summary

Aotearoa Clinical Trials (ACT) partnered with SupaHuman to integrate the QC AI Copilot into its clinical trial management processes. This AI-driven solution aims to enhance data accuracy, compliance, and operational efficiency throughout clinical trials.

Aotearoa Clinical Trials (ACT) partnered with SupaHuman to integrate the QC AI Copilot into its clinical trial management processes. This AI-driven solution aims to enhance data accuracy, compliance, and operational efficiency throughout clinical trials.

Results
70%

Expected 70% reduction in manual quality control workload, with improved compliance and operational efficiency.

We anticipate that the QC AI Copilot will significantly improve our operational efficiency and data compliance, revolutionising how we conduct trials.

Dr Edward Watson, Director, Aotearoa Clinical Trials

Project Details
Client

Aotearoa Clinical Trials

Industry

Healthcare

Company size

100-500

The Challenge

ACT needed a system capable of managing complex logistics, ensuring data integrity, and maintaining regulatory compliance, while reducing manual workloads and improving overall data quality in its clinical trials.

The Solution

SupaHuman is developing the QC AI Copilot, which will automate data validation, document verification, and protocol monitoring. The AI will ensure that trial data adheres to international and local regulatory standards, streamline auditing processes, and improve staff training through personalised modules.

Curious how we delivered this solution? Ask us to learn more!

Expected Impact

The AI copilot is expected to reduce manual data management tasks, enhance the accuracy of trial data, and ensure compliance with regulatory requirements, enabling ACT to maintain its high standards in clinical research.

Results
70%

Expected 70% reduction in manual quality control workload, with improved compliance and operational efficiency.

We anticipate that the QC AI Copilot will significantly improve our operational efficiency and data compliance, revolutionising how we conduct trials.

Dr Edward Watson, Director, Aotearoa Clinical Trials